COBNABEXAGENE ANVUPARVOVEC HEXB
UNII D35L53F823

Substance Identification & Data

This profile provides standardized clinical and technical data for Cobnabexagene Anvuparvovec Hexb, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D35L53F823.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
D35L53F823
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
COBNABEXAGENE ANVUPARVOVEC HEXB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cobnabexagene Anvuparvovec Hexb. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

AAVRH8-HEXB (CONTAINS THE TRANSGENE WTHEXA WHICH ENCODES THE .BETA.-HEXOSAMINIDASE B PROTEIN)
COBNABEXAGENE ANVUPARVOVEC HEXB
COBNABEXAGENE ANVUPARVOVEC HEXB [USAN]

Technical Codes

AAVRH8-HEXB
AXO-AAV-GM2 COMPONENT AAVRH8-HEXB